
THOUSANDS of patients with multiple sclerosis are being denied access to a life-changing medicine that can reduce painful muscle spasms. The cannabis-based drug Sativex is approved for use on the NHS but patchy funding across England means many sufferers are unable to get a prescription.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.